Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure

Circulation

Volumn 93, Issue 11, 1996, Pages 2037-2042

  Clarkson, Peter B M ^a   Wheeldon, Nigel M ^b   MacFadyen, Robert J ^a   Pringle, Stuart D ^a   MacDonald, Thomas M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

heart failure; hemodynamics; Peptides

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLE; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART FAILURE; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RADIOISOTOPE VENTRICULOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0029993057     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.11.2037     Document Type: Article

References (53)

1. Wheeldon NM, Clarkson P, MacDonald TM. Diastolic heart failure. Eur Heart J. 1994;15:1689-1697.
2. Davies SW, Fussell AL, Jordan SL, Poole-Wilson PA, Lipkin DP. Abnormal diastolic filling patterns in chronic heart failure: relationship to exercise capacity. Eur Heart J. 1992;13:749-757.
3. Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Am J Cardiol. 1984;54:778-782.
4. Soufer R, Wohlgelertner D, Vita NA, Amechestegui M, Sostman HD, Berger HG, Zaret BL. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol. 1985;55: 1032-1036.
5. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick A, McDevitt DG, Struthers AD. Echocardiography in chronic heart failure in the community. Q J Med. 1993;86:17-23.
6. Echeverria HH, Bilsker MS, Mycrburg RJ, Kessler KM. Congestive heart failure: echocardiographic insights. Am J Med. 1983;75: 750-755.
7. Remes J, Reunanen A, Aromaa AA, Pyorala K. Incidence of heart failure in eastern Finland: a population based surveillance study. Eur Heart J. 1992;13:588-593.
8. Shenoy MM, Khanna A, Moosa N, Greif E, Friedman SA. Hypertrophic cardiomyopathy in the elderly: a frequently misdiagnosed disease Arch Intern Med. 1986;146:658-661.
9. Luchi RJ, Snow E, Luchi JM, Nelson CJ, Pircher FJ. Left ventricular function in hospitalized geriatric patients. J Am Geriatr Soc. 1982;30:700-705.
10. Kessler KM. Heart failure with normal systolic function: update of prevalence, differential diagnosis, prognosis and therapy. Arch Intern Med. 1988;148:2109-2111.
11. Topol EJ, Traill TA, Fortun NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med. 1985;312:277-283.
12. Smith VE, Katz AM. Inotropic and lusitropic abnormalities as the basis for heart failure. Heart Failure. April/May 1987:55-65.
13. Clarkson P, Wheeldon NM, MacDonald TM. Left ventricular diastolic dysfunction. Q J Med. 1994;87:143-148.
14. Brogan WC, Hillis D, Flores ED, Lange RA. The natural history of isolated left ventricular diastolic dysfunction. Am J Med. 1992;92: 627-630.
15. Cohn JN, Johnson GJ, and Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction: the V-HeFT study. Circulation. 1990;81(suppl III):III-48-III-53.
16. Lewis JF, Maron BJ. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol. 1989;13: 36-45.
17. Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol. 1991;17:1065-1072.
18. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988;332:78-81.
19. Saito Y, Nakao K, Itoh H, Yamada T, Mukoyama M, Arai H, Hosoda K, Shirakami G, Suga S, Minamino N. Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun. 1989;158:360-368.
20. Hosoda K, Nakao K, Mukoyama M, Saito Y, Jougasaki M, Shirakami G, Suga S, Ogawa Y, Yasue H, Imura H. Expression of brain natriuretic peptide gene in human heart: production in the ventricle. Hypertension. 1991;17:1152-1156.
21. Lang CC, Choy A-MJ, Struthers AD. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin Sci (Colch). 1992;83:519-527.
22. Hashiguchi T, Higuchi K, Ohashi M, Minamino K, Kamgawa K, Matsuo H, Nawata H. Porcine brain natriuretic peptide, another modulator of bovine adrenocortical steroidogenesis. FEBS Lett. 1988;236:455-461.
23. Hirata Y, Schichiri M, Emori T, Marumo K, Kangawa K, Matsuo H. Brain natriuretic peptide interacts with atrial natriuretic peptide receptor in cultured rat smooth muscle cells. FEBS Lett. 1988;238: 415-418.
24. Oehlenschlager WF, Baron PA, Schomer H, Currie MC. Atrial and brain natriuretic peptides share binding sites in the kidney and the heart. Eur J Pharmacol. 1989;161:159-164.
25. Clarkson PBM, Wheeldon NM, MacLeod C, Coutie W, MacDonald TM. Brain natriuretic peptide: effect on left ventricular filling patterns in healthy subjects. Clin Sci (Colch). 1995;88: 159-164.
26. Yamamoto K, Burnett JC, Redfield MM. Unique effects of brain natriuretic peptide on left ventricular systolic and diastolic function. In: Proceedings of Heart Failure '95; April 1-4, 1995; Amsterdam, Netherlands. Abstract P255.
27. Yokota M, Miyahara T, Iwase M, Watanabe M, Matsunami T, Kamihara S, Koide M, Saito H, Takeuchi J. Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina. Circulation. 1990;81:1887-1898.
28. Cuocolo A, Sax FL, Brush JE, Maron BJ, Bacharach SL, Bonow RO. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension: diastolic mechanism for systolic dysfunction during exercise. Circulation. 1990;81:978-986.
29. Gilbert JC, Glantz SA. Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circ Res. 1989;64:827-852.
30. Sobue T, Yokota M, Iwase M, Ishihara H. Influence of left ventricular hypertrophy on left ventricular function during dynamic exercise in the presence or absence of coronary artery disease. J Am Coll Cardiol. 1995;25:91-98.
31. Labovitz AJ, Pearson AC. Evaluation of left ventricular diastolic function: clinical relevance and recent Doppler echocardiographic insights. Am Heart J. 1987;114:836-851.
32. Strauer BE. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol. 1979;44:999-1006.
33. Breisch EA, Houser SR, Carey RA, Spann JF, Bore AA. Myocardial blood flow and capillary density in chronic pressure overload in the feline left ventricle. Cardiovasc Res. 1980;14:469-475.
34. Strauer BE. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol. 1990;65:34G-41G.
35. Hittinger L, Shannon RP, Kohin S, Manders WT, Kelly P, Vatner SF. Exercise-induced subendocardial dysfunction in dogs with left ventricular hypertrophy. Circ Res. 1990;66:329-343.
36. Gwathmey JK, Morgan JP. Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res. 1985; 57:836-843.
37. Apstein CS, Lorell BH. The physiological basis of left ventricular diastolic dysfunction. J Cardiac Surg. 1988;3:475-485.
38. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res. 1988;62:757-765.
39. Brilla CG, Janicki JS, Weber KT. Cardioprotective effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991;83:1771-1779.
40. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat ventricle. Circ Res. 1989;64:1041-1050.
41. Thadani U, West RO, Mathew TM, Parker JO. Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease. Am J Cardiol. 1977;39:776-783.
42. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Saito Y, Nakao K, Imura H. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 1991;84:1581-1588.
43. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993;76: 91-96.
44. Poole-Wilson PA, Buller NP. Causes of symptoms in chronic congestive heart failure and implications for treatment. Am J Cardiol. 1988;62:31A-34A.
45. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance. Circulation. 1989;79:324-329.
46. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure: muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989; 80:769-781.
47. Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation. 1993;87:470-475.
48. Minotti JR, Christopher I, Massie BM. Skeletal muscle function, morphology and metabolism in patients with congestive heart failure. Chest. 1992;101:333S-339S.
49. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Colch). 1995;88:551-556.
50. Matsumoto A, Hirata Y, Momomura S-I, Suzuki G, Yokoyama I, Sata M, Ohtani Y, Serizawa T. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J. 1995;129:139-145.
51. Nawata H, Ohashi M, Haji M, Takayanagi R, Higuchi K, Fujio N, Hashiguchi T, Ogo A, Nakao R, Ohnaka K. Atrial and brain natriuretic peptide in adrenal steroidogenesis. J Steroid Biochem Mol Biol. 1991;40:367-379.
52. Stephenson SL, Kenny AJ. The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is inhibited by endopeptidase 24.11. Biochem J. 1991;291:83-88.
53. Laragh JH. Atrial natriuretic hormone, the renin aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med. 1985; 313:1330-1340.